source,author,title,description,publishedAT,content
marketscreenercom,globenewswire,procept biorobotics® receives us fda investigational device exemption to investigate aquablation® therapy for prostate cancer,"(marketscreenercom) redwood city, calif, sept 12, 2023 -- procept biorobotics corporation , a global leader in surgical robotics, announced today the investigational device exemption approval from the us food and drug administration to investigate the sa…",2023-09-12T12:02:02Z,"redwood city, calif, sept 12, 2023 (globe newswire) -- procept biorobotics corporation (nasdaq: prct) (procept biorobotics), a global leader in surgical robotics, announced today the investigationa… [+7266 chars]"
